FI955256L - Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä - Google Patents

Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä Download PDF

Info

Publication number
FI955256L
FI955256L FI955256A FI955256A FI955256L FI 955256 L FI955256 L FI 955256L FI 955256 A FI955256 A FI 955256A FI 955256 A FI955256 A FI 955256A FI 955256 L FI955256 L FI 955256L
Authority
FI
Finland
Prior art keywords
phosphonosulfonate
squalene synthase
inhibitor salts
inhibitor
salts
Prior art date
Application number
FI955256A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955256A0 (fi
FI955256A7 (fi
Inventor
Yadagiri Pendri
Chung-Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Peter Timmins
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI955256A0 publication Critical patent/FI955256A0/fi
Publication of FI955256L publication Critical patent/FI955256L/fi
Publication of FI955256A7 publication Critical patent/FI955256A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
FI955256A 1994-11-03 1995-11-02 Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä FI955256A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (3)

Publication Number Publication Date
FI955256A0 FI955256A0 (fi) 1995-11-02
FI955256L true FI955256L (fi) 1996-05-04
FI955256A7 FI955256A7 (fi) 1996-05-04

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955256A FI955256A7 (fi) 1994-11-03 1995-11-02 Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä

Country Status (14)

Country Link
EP (1) EP0710665A1 (forum.php)
JP (1) JPH08208672A (forum.php)
KR (1) KR960017680A (forum.php)
CN (1) CN1130188A (forum.php)
AU (1) AU3458795A (forum.php)
CA (1) CA2159850A1 (forum.php)
CZ (1) CZ279595A3 (forum.php)
FI (1) FI955256A7 (forum.php)
HU (1) HUT73140A (forum.php)
IL (1) IL115537A0 (forum.php)
NO (1) NO954389L (forum.php)
PL (1) PL311218A1 (forum.php)
TW (1) TW318852B (forum.php)
ZA (1) ZA959326B (forum.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
AU2002212741A1 (en) * 2000-11-09 2002-05-21 Takeda Chemical Industries Ltd. High-density lipoprotein-cholesterol level elevating agent
CN101198252A (zh) 2005-04-18 2008-06-11 加利福尼亚大学董事会 用于细菌感染的抗微生物疗法
EP2020857A4 (en) * 2006-05-12 2010-06-09 Univ California ANTIMICROBIAL THERAPY OF BACTERIAL INFECTIONS
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
TW318852B (forum.php) 1997-11-01
CN1130188A (zh) 1996-09-04
IL115537A0 (en) 1996-01-19
HUT73140A (en) 1996-06-28
PL311218A1 (en) 1996-05-13
CZ279595A3 (en) 1996-08-14
NO954389L (no) 1996-05-06
NO954389D0 (no) 1995-11-02
FI955256A0 (fi) 1995-11-02
CA2159850A1 (en) 1996-05-04
ZA959326B (en) 1997-05-05
AU3458795A (en) 1996-05-09
FI955256A7 (fi) 1996-05-04
KR960017680A (ko) 1996-06-17
HU9503136D0 (en) 1995-12-28
JPH08208672A (ja) 1996-08-13
EP0710665A1 (en) 1996-05-08

Similar Documents

Publication Publication Date Title
FI944048L (fi) Mikrosomaalisen triglyseridia siirtävän proteiinin inhibiittoreita ja menetelmä
FI973416L (fi) Mikrosomaalisen triglyseridin siirtäjäproteiinin inhibiittoreita ja menetelmä
NO2008002I1 (no) Protiokonazol og salter derav
FI963597A7 (fi) Isoprenyylitransferaasi-inhibiittoreita
FI952616L (fi) Työkalu ja menetelmä sen valmistamiseksi
FI972062A7 (fi) Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
FI962030L (fi) Menetelmä ja laite dekoodering optimoimiseksi
FI965019A7 (fi) Entsyymi-inhibiittoreita
FI972260A7 (fi) Laite ja menetelmä pintojen käsittelemiseksi
FI982095A7 (fi) Menetelmä muistin toteuttamiseksi ja muistijärjestely
FI955362A0 (fi) Symmetrointilaite ja menetelmä sen suunnittelemiseksi
FI974494L (fi) Paikannusmenetelmä ja paikannusjärjestely
DE69523060D1 (de) Luziferase-markierungsmethode
EE04664B1 (et) Pulverisaator ja pulverisatsioonimeetod
FI961937L (fi) Juoma ja menetelmä sen valmistamiseksi
FI955958A7 (fi) Laite ja menetelmä suurien tilojen jäähdyttämiseksi
EE9700170A (et) Aminoetüületanoolamiini ja/või hüdroksüetüülpiperasiini saamise meetod
FI963811L (fi) Menetelmät kalpaiinin aktivoitumisen ilmaisemiseksi ja kalpaiinin inhibiittoreiden tunnistamiseksi
FI934747A7 (fi) a-fosfonosulfonaattiskaveleenisyntetaasi-inhibiittoreita ja menetelmä
LV11325A (lv) Skvalena sintetazes inhibitori
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
FI955256A7 (fi) Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä
FI104239B1 (fi) Menetelmä ja laitteisto levymäisen kappaleen jakamiseksi
FI972464A7 (fi) Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed